Fucoxanthin metabolites exert anti-fibrogenic and antioxidant effects in hepatic stellate cells

We previously reported an anti-fibrogenic effects of fucoxanthin in hepatic stellate cells (HSCs). However, it is unknown whether the primary metabolites of fucoxanthin, such as fucoxanthinol (FCN) and amarouciaxanthin A (ACXA), exert similar functions in fibrogenesis pathways. In this study, we inv...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yang Li, Mi-Bo Kim, Young-Ki Park, Ji-Young Lee
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/e4deeafcca9745c5aad33f2fb3765696
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e4deeafcca9745c5aad33f2fb3765696
record_format dspace
spelling oai:doaj.org-article:e4deeafcca9745c5aad33f2fb37656962021-12-02T05:03:42ZFucoxanthin metabolites exert anti-fibrogenic and antioxidant effects in hepatic stellate cells2666-154310.1016/j.jafr.2021.100245https://doaj.org/article/e4deeafcca9745c5aad33f2fb37656962021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2666154321001472https://doaj.org/toc/2666-1543We previously reported an anti-fibrogenic effects of fucoxanthin in hepatic stellate cells (HSCs). However, it is unknown whether the primary metabolites of fucoxanthin, such as fucoxanthinol (FCN) and amarouciaxanthin A (ACXA), exert similar functions in fibrogenesis pathways. In this study, we investigated the role of FCN and ACXA in the regulation of transforming growth factor β1 (TGFβ1)-induced pro-fibrogenic gene expression and oxidative stress in LX-2 cells, a human HSC cell line. TGFβ1 increased mRNA expression of pro-fibrogenic genes, such as α smooth muscle actin, procollagen type I α1 (COL1A1), COL3A1, and COL6A1, which FCN and ACXA significantly suppressed. Also, an increase in the protein level of COL1A1 by TGFβ1 was markedly decreased by ACXA. Furthermore, FCN and ACXA significantly inhibited TGFβ1-induced reactive oxygen species (ROS) accumulation with concomitantly decreasing antioxidant gene expression. Mechanistically, FCN and ACXA markedly increased TGFβ1-induced nuclear translocation of nuclear E2-related factor 2 (NRF2); however, they significantly attenuated TGFβ1-induced NFE2L2 and its target gene heme oxygenase-1 expression. The results suggest that FCN and ACXA exert anti-fibrogenic and antioxidant properties by inhibiting TGFβ1-induced pro-fibrogenic gene expression and ROS accumulation in LX-2 cells.Yang LiMi-Bo KimYoung-Ki ParkJi-Young LeeElsevierarticleFucoxanthinFucoxanthinolAmarouciaxanthin AAnti-fibrogenicAntioxidantHepatic stellate cellAgriculture (General)S1-972Nutrition. Foods and food supplyTX341-641ENJournal of Agriculture and Food Research, Vol 6, Iss , Pp 100245- (2021)
institution DOAJ
collection DOAJ
language EN
topic Fucoxanthin
Fucoxanthinol
Amarouciaxanthin A
Anti-fibrogenic
Antioxidant
Hepatic stellate cell
Agriculture (General)
S1-972
Nutrition. Foods and food supply
TX341-641
spellingShingle Fucoxanthin
Fucoxanthinol
Amarouciaxanthin A
Anti-fibrogenic
Antioxidant
Hepatic stellate cell
Agriculture (General)
S1-972
Nutrition. Foods and food supply
TX341-641
Yang Li
Mi-Bo Kim
Young-Ki Park
Ji-Young Lee
Fucoxanthin metabolites exert anti-fibrogenic and antioxidant effects in hepatic stellate cells
description We previously reported an anti-fibrogenic effects of fucoxanthin in hepatic stellate cells (HSCs). However, it is unknown whether the primary metabolites of fucoxanthin, such as fucoxanthinol (FCN) and amarouciaxanthin A (ACXA), exert similar functions in fibrogenesis pathways. In this study, we investigated the role of FCN and ACXA in the regulation of transforming growth factor β1 (TGFβ1)-induced pro-fibrogenic gene expression and oxidative stress in LX-2 cells, a human HSC cell line. TGFβ1 increased mRNA expression of pro-fibrogenic genes, such as α smooth muscle actin, procollagen type I α1 (COL1A1), COL3A1, and COL6A1, which FCN and ACXA significantly suppressed. Also, an increase in the protein level of COL1A1 by TGFβ1 was markedly decreased by ACXA. Furthermore, FCN and ACXA significantly inhibited TGFβ1-induced reactive oxygen species (ROS) accumulation with concomitantly decreasing antioxidant gene expression. Mechanistically, FCN and ACXA markedly increased TGFβ1-induced nuclear translocation of nuclear E2-related factor 2 (NRF2); however, they significantly attenuated TGFβ1-induced NFE2L2 and its target gene heme oxygenase-1 expression. The results suggest that FCN and ACXA exert anti-fibrogenic and antioxidant properties by inhibiting TGFβ1-induced pro-fibrogenic gene expression and ROS accumulation in LX-2 cells.
format article
author Yang Li
Mi-Bo Kim
Young-Ki Park
Ji-Young Lee
author_facet Yang Li
Mi-Bo Kim
Young-Ki Park
Ji-Young Lee
author_sort Yang Li
title Fucoxanthin metabolites exert anti-fibrogenic and antioxidant effects in hepatic stellate cells
title_short Fucoxanthin metabolites exert anti-fibrogenic and antioxidant effects in hepatic stellate cells
title_full Fucoxanthin metabolites exert anti-fibrogenic and antioxidant effects in hepatic stellate cells
title_fullStr Fucoxanthin metabolites exert anti-fibrogenic and antioxidant effects in hepatic stellate cells
title_full_unstemmed Fucoxanthin metabolites exert anti-fibrogenic and antioxidant effects in hepatic stellate cells
title_sort fucoxanthin metabolites exert anti-fibrogenic and antioxidant effects in hepatic stellate cells
publisher Elsevier
publishDate 2021
url https://doaj.org/article/e4deeafcca9745c5aad33f2fb3765696
work_keys_str_mv AT yangli fucoxanthinmetabolitesexertantifibrogenicandantioxidanteffectsinhepaticstellatecells
AT mibokim fucoxanthinmetabolitesexertantifibrogenicandantioxidanteffectsinhepaticstellatecells
AT youngkipark fucoxanthinmetabolitesexertantifibrogenicandantioxidanteffectsinhepaticstellatecells
AT jiyounglee fucoxanthinmetabolitesexertantifibrogenicandantioxidanteffectsinhepaticstellatecells
_version_ 1718400683264180224